BRIDGEWATER, N.J., Jan. 29, 2025 (GLOBE NEWSWIRE) -- (“Vyluma”), a biopharmaceutical company advancing novel treatments for ...
Rampant crime and drug use. That’s what a court has heard was witnessed outside of Ontario’s so-called safe injection sites.
SAN DIEGO - Regulus Therapeutics Inc . (NASDAQ:RGLS), a biopharmaceutical company currently trading at $1.17 per share, today announced significant clinical and regulatory advancements in its ...
Pharmacies in the UK face significant cuts, so it’s perhaps not surprising that they sell many unevidenced lifestyle products ...
Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, is pleased to invite investors to a webinar on February 5 ...
Under the UK's Pharmacy First initiative, people are encouraged to see their pharmacist before consulting their GP - especially for minor ailments ...